A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma.
Berenson JR, Yellin O, Shamasunder HK, Chen CS, Charu V, Woliver TB, Sanani S, Schlutz M, Nassir Y, Swift RA, Andreu-Vieyra C, Vescio R.
Berenson JR, et al. Among authors: andreu vieyra c.
Support Care Cancer. 2015 Jun;23(6):1503-12. doi: 10.1007/s00520-014-2486-7. Epub 2014 Nov 5.
Support Care Cancer. 2015.
PMID: 25370889
Clinical Trial.